Literature DB >> 21362629

Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors.

Kyungsil Yoon1, Syng-Ook Lee, Sung-Dae Cho, Kyounghyun Kim, Shaheen Khan, Stephen Safe.   

Abstract

NR4A1 (Nur77, TR3) is overexpressed in pancreatic tumors and activation of TR3 by 1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane (DIM-C-pPhOCH(3)) inhibits cell and tumor growth and induces apoptosis. Microarray analysis demonstrates that in L3.6pL pancreatic cancer cells DIM-C-pPhOCH(3) induces genes associated with metabolism, homeostasis, signal transduction, transcription, stress, transport, immune responses, growth inhibition and apoptosis. Among the most highly induced growth inhibitory and proapoptotic genes including activating transcription factor 3 (ATF3), p21, cystathionase, dual specificity phosphatase 1 and growth differentiation factor 15, RNA interference studies demonstrated that induction of all but the later gene by DIM-C-pPhOCH(3) were TR3-dependent. We also observed that DIM-C-pPhOCH(3) induced Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and induction of TRAIL was ATF3 dependent. Results of this and previous studies demonstrate that TR3 is unique among nuclear receptors since nuclear TR3 is activated or deactivated by diindolylmethane derivatives to induce different apoptotic and growth inhibitory pathways that inhibit pancreatic cancer cell and tumor growth.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21362629      PMCID: PMC3106434          DOI: 10.1093/carcin/bgr040

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  43 in total

1.  Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.

Authors:  Wassim Kassouf; Sudhakar Chintharlapalli; Maen Abdelrahim; Gina Nelkin; Stephen Safe; Ashish M Kamat
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

2.  Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation.

Authors:  Nuno M M Pires; Thijs W H Pols; Margreet R de Vries; Claudia M van Tiel; Peter I Bonta; Mariska Vos; E Karin Arkenbout; Hans Pannekoek; J Wouter Jukema; Paul H A Quax; Carlie J M de Vries
Journal:  Circulation       Date:  2007-01-22       Impact factor: 29.690

3.  Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination.

Authors:  Chunhong Yan; Dan Lu; Tsonwin Hai; Douglas D Boyd
Journal:  EMBO J       Date:  2005-06-02       Impact factor: 11.598

4.  Activation of Nur77 by selected 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways.

Authors:  Sudhakar Chintharlapalli; Robert Burghardt; Sabitha Papineni; Shashi Ramaiah; Kyungsil Yoon; Stephen Safe
Journal:  J Biol Chem       Date:  2005-05-03       Impact factor: 5.157

5.  Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways.

Authors:  Sung Dae Cho; Kyungsil Yoon; Sudhakar Chintharlapalli; Maen Abdelrahim; Ping Lei; Stanley Hamilton; Shaheen Khan; Shashi K Ramaiah; Stephen Safe
Journal:  Cancer Res       Date:  2007-01-15       Impact factor: 12.701

6.  1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways.

Authors:  Sudhakar Chintharlapalli; Sabitha Papineni; Stephen Safe
Journal:  Mol Pharmacol       Date:  2006-11-08       Impact factor: 4.436

7.  Reduction of the incidence and severity of collagen-induced arthritis by constitutive Nur77 expression in the T cell lineage.

Authors:  Swanthri De Silva; Shuhua Han; Xuejun Zhang; David P Huston; Astar Winoto; Biao Zheng
Journal:  Arthritis Rheum       Date:  2005-01

8.  Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins.

Authors:  Jun Hong; Ismael Samudio; Shengxi Liu; Maen Abdelrahim; Stephen Safe
Journal:  Endocrinology       Date:  2004-09-02       Impact factor: 4.736

9.  Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis.

Authors:  Dan Lu; Curt D Wolfgang; Tsonwin Hai
Journal:  J Biol Chem       Date:  2006-02-09       Impact factor: 5.157

10.  Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle.

Authors:  Lily C Chao; Zidong Zhang; Liming Pei; Tsugumichi Saito; Peter Tontonoz; Paul F Pilch
Journal:  Mol Endocrinol       Date:  2007-06-05
View more
  26 in total

Review 1.  Nuclear receptors and pathogenesis of pancreatic cancer.

Authors:  Simone Polvani; Mirko Tarocchi; Sara Tempesti; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 2.  Nurr1-Based Therapies for Parkinson's Disease.

Authors:  Jie Dong; Song Li; Jing-Lin Mo; Huai-Bin Cai; Wei-Dong Le
Journal:  CNS Neurosci Ther       Date:  2016-03-25       Impact factor: 5.243

3.  The Nurr1 Activator 1,1-Bis(3'-Indolyl)-1-(p-Chlorophenyl)Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κB.

Authors:  Briana R De Miranda; Katriana A Popichak; Sean L Hammond; Bryce A Jorgensen; Aaron T Phillips; Stephen Safe; Ronald B Tjalkens
Journal:  Mol Pharmacol       Date:  2015-04-09       Impact factor: 4.436

Review 4.  Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.

Authors:  Sanjeev Banerjee; Dejuan Kong; Zhiwei Wang; Bin Bao; Gilda G Hillman; Fazlul H Sarkar
Journal:  Mutat Res       Date:  2011-06-15       Impact factor: 2.433

5.  Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.

Authors:  Briana R De Miranda; Katriana A Popichak; Sean L Hammond; James A Miller; Stephen Safe; Ronald B Tjalkens
Journal:  Toxicol Sci       Date:  2014-11-17       Impact factor: 4.849

6.  Vorinostat in combination with bortezomib in patients with advanced malignancies directly alters transcription of target genes.

Authors:  Jill M Kolesar; Anne M Traynor; Kyle D Holen; Tien Hoang; Songwon Seo; Kyungmann Kim; Dona Alberti; Igor Espinoza-Delgado; John J Wright; George Wilding; Howard H Bailey; William R Schelman
Journal:  Cancer Chemother Pharmacol       Date:  2013-08-01       Impact factor: 3.333

7.  A novel diindolylmethane analog, 1,1-bis(3'-indolyl)-1-(p-chlorophenyl) methane, inhibits the tumor necrosis factor-induced inflammatory response in primary murine synovial fibroblasts through a Nurr1-dependent mechanism.

Authors:  Maryam F Afzali; Katriana A Popichak; Lindsey H Burton; Anna L Klochak; William J Wilson; Stephen Safe; Ronald B Tjalkens; Marie E Legare
Journal:  Mol Immunol       Date:  2018-06-02       Impact factor: 4.407

8.  Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.

Authors:  Syng-Ook Lee; Xi Li; Erik Hedrick; Un-Ho Jin; Ronald B Tjalkens; Donald S Backos; Li Li; Yi Zhang; Qiao Wu; Stephen Safe
Journal:  Mol Endocrinol       Date:  2014-08-06

9.  Ring-substituted analogs of 3,3'-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells.

Authors:  A A Goldberg; V I Titorenko; A Beach; K Abdelbaqi; S Safe; J T Sanderson
Journal:  Invest New Drugs       Date:  2013-05-25       Impact factor: 3.850

10.  Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.

Authors:  Shauna N Vasilatos; Tiffany A Katz; Steffi Oesterreich; Yong Wan; Nancy E Davidson; Yi Huang
Journal:  Carcinogenesis       Date:  2013-01-25       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.